Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Topical Non-Steroidal Anti-Inflammatory Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Topical Non-Steroidal Anti-Inflammatory Drugs Industry Forecast” looks at past sales and reviews total world Topical Non-Steroidal Anti-Inflammatory Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Topical Non-Steroidal Anti-Inflammatory Drugs sales for 2024 through 2030. With Topical Non-Steroidal Anti-Inflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Non-Steroidal Anti-Inflammatory Drugs industry.
This Insight Report provides a comprehensive analysis of the global Topical Non-Steroidal Anti-Inflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Topical Non-Steroidal Anti-Inflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical Non-Steroidal Anti-Inflammatory Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Non-Steroidal Anti-Inflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Non-Steroidal Anti-Inflammatory Drugs.
United States market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Topical Non-Steroidal Anti-Inflammatory Drugs players cover Roche, Viatris, Teva Pharmaceutical Industries, Sanofi, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Non-Steroidal Anti-Inflammatory Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Topical Non-Steroidal Anti-Inflammatory Drugs market?
What factors are driving Topical Non-Steroidal Anti-Inflammatory Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Topical Non-Steroidal Anti-Inflammatory Drugs market opportunities vary by end market size?
How does Topical Non-Steroidal Anti-Inflammatory Drugs break out by Type, by Application?
The global Topical Non-Steroidal Anti-Inflammatory Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Topical Non-Steroidal Anti-Inflammatory Drugs Industry Forecast” looks at past sales and reviews total world Topical Non-Steroidal Anti-Inflammatory Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Topical Non-Steroidal Anti-Inflammatory Drugs sales for 2024 through 2030. With Topical Non-Steroidal Anti-Inflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Non-Steroidal Anti-Inflammatory Drugs industry.
This Insight Report provides a comprehensive analysis of the global Topical Non-Steroidal Anti-Inflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Topical Non-Steroidal Anti-Inflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical Non-Steroidal Anti-Inflammatory Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Non-Steroidal Anti-Inflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Non-Steroidal Anti-Inflammatory Drugs.
United States market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Topical Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Topical Non-Steroidal Anti-Inflammatory Drugs players cover Roche, Viatris, Teva Pharmaceutical Industries, Sanofi, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Non-Steroidal Anti-Inflammatory Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Gel
- Cream
- Liquid Spray
- Paste
- Other
- Skin Inflammation
- Arthritis
- Sprains
- Everyday Injuries
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Viatris
- Teva Pharmaceutical Industries
- Sanofi
- Pfizer
- GlaxoSmithKline
- Novartis
- Zydus Cadila
- Boehringer Ingelheim International
- Apotex
- AstraZeneca
- Horizon Therapeutics
- Johnson & Johnson
- Bayer
- Perrigo Company
- Tolmar Pharmaceuticals
- Sun Pharmaceutical Industries
- Assertio Therapeutics
- Daiichi Sankyo
What is the 10-year outlook for the global Topical Non-Steroidal Anti-Inflammatory Drugs market?
What factors are driving Topical Non-Steroidal Anti-Inflammatory Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Topical Non-Steroidal Anti-Inflammatory Drugs market opportunities vary by end market size?
How does Topical Non-Steroidal Anti-Inflammatory Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Topical Non-Steroidal Anti-Inflammatory Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Topical Non-Steroidal Anti-Inflammatory Drugs by Country/Region, 2019, 2023 & 2030
2.2 Topical Non-Steroidal Anti-Inflammatory Drugs Segment by Type
2.2.1 Gel
2.2.2 Cream
2.2.3 Liquid Spray
2.2.4 Paste
2.2.5 Other
2.3 Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type
2.3.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Type (2019-2024)
2.4 Topical Non-Steroidal Anti-Inflammatory Drugs Segment by Application
2.4.1 Skin Inflammation
2.4.2 Arthritis
2.4.3 Sprains
2.4.4 Everyday Injuries
2.4.5 Other
2.5 Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application
2.5.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Breakdown Data by Company
3.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Company (2019-2024)
3.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Company (2019-2024)
3.2.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Company
3.4 Key Manufacturers Topical Non-Steroidal Anti-Inflammatory Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Topical Non-Steroidal Anti-Inflammatory Drugs Product Location Distribution
3.4.2 Players Topical Non-Steroidal Anti-Inflammatory Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TOPICAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth
4.4 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth
4.5 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth
4.6 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth
5 AMERICAS
5.1 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country
5.1.1 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024)
5.1.2 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024)
5.2 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
5.3 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region
6.1.1 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2024)
6.1.2 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2024)
6.2 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
6.3 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Topical Non-Steroidal Anti-Inflammatory Drugs by Country
7.1.1 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024)
7.1.2 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024)
7.2 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
7.3 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs by Country
8.1.1 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Topical Non-Steroidal Anti-Inflammatory Drugs
10.3 Manufacturing Process Analysis of Topical Non-Steroidal Anti-Inflammatory Drugs
10.4 Industry Chain Structure of Topical Non-Steroidal Anti-Inflammatory Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Topical Non-Steroidal Anti-Inflammatory Drugs Distributors
11.3 Topical Non-Steroidal Anti-Inflammatory Drugs Customer
12 WORLD FORECAST REVIEW FOR TOPICAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY GEOGRAPHIC REGION
12.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Region
12.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2025-2030)
12.1.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Topical Non-Steroidal Anti-Inflammatory Drugs Forecast by Type (2025-2030)
12.7 Global Topical Non-Steroidal Anti-Inflammatory Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.1.3 Roche Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Viatris
13.2.1 Viatris Company Information
13.2.2 Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.2.3 Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Viatris Main Business Overview
13.2.5 Viatris Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.4.3 Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.5.3 Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.7.3 Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Zydus Cadila
13.8.1 Zydus Cadila Company Information
13.8.2 Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.8.3 Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zydus Cadila Main Business Overview
13.8.5 Zydus Cadila Latest Developments
13.9 Boehringer Ingelheim International
13.9.1 Boehringer Ingelheim International Company Information
13.9.2 Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.9.3 Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Boehringer Ingelheim International Main Business Overview
13.9.5 Boehringer Ingelheim International Latest Developments
13.10 Apotex
13.10.1 Apotex Company Information
13.10.2 Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.10.3 Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Apotex Main Business Overview
13.10.5 Apotex Latest Developments
13.11 AstraZeneca
13.11.1 AstraZeneca Company Information
13.11.2 AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.11.3 AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AstraZeneca Main Business Overview
13.11.5 AstraZeneca Latest Developments
13.12 Horizon Therapeutics
13.12.1 Horizon Therapeutics Company Information
13.12.2 Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.12.3 Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Horizon Therapeutics Main Business Overview
13.12.5 Horizon Therapeutics Latest Developments
13.13 Johnson & Johnson
13.13.1 Johnson & Johnson Company Information
13.13.2 Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.13.3 Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Johnson & Johnson Main Business Overview
13.13.5 Johnson & Johnson Latest Developments
13.14 Bayer
13.14.1 Bayer Company Information
13.14.2 Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.14.3 Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Bayer Main Business Overview
13.14.5 Bayer Latest Developments
13.15 Perrigo Company
13.15.1 Perrigo Company Company Information
13.15.2 Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.15.3 Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Perrigo Company Main Business Overview
13.15.5 Perrigo Company Latest Developments
13.16 Tolmar Pharmaceuticals
13.16.1 Tolmar Pharmaceuticals Company Information
13.16.2 Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.16.3 Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Tolmar Pharmaceuticals Main Business Overview
13.16.5 Tolmar Pharmaceuticals Latest Developments
13.17 Sun Pharmaceutical Industries
13.17.1 Sun Pharmaceutical Industries Company Information
13.17.2 Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.17.3 Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Sun Pharmaceutical Industries Main Business Overview
13.17.5 Sun Pharmaceutical Industries Latest Developments
13.18 Assertio Therapeutics
13.18.1 Assertio Therapeutics Company Information
13.18.2 Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.18.3 Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Assertio Therapeutics Main Business Overview
13.18.5 Assertio Therapeutics Latest Developments
13.19 Daiichi Sankyo
13.19.1 Daiichi Sankyo Company Information
13.19.2 Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.19.3 Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Daiichi Sankyo Main Business Overview
13.19.5 Daiichi Sankyo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Topical Non-Steroidal Anti-Inflammatory Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Topical Non-Steroidal Anti-Inflammatory Drugs by Country/Region, 2019, 2023 & 2030
2.2 Topical Non-Steroidal Anti-Inflammatory Drugs Segment by Type
2.2.1 Gel
2.2.2 Cream
2.2.3 Liquid Spray
2.2.4 Paste
2.2.5 Other
2.3 Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type
2.3.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Type (2019-2024)
2.4 Topical Non-Steroidal Anti-Inflammatory Drugs Segment by Application
2.4.1 Skin Inflammation
2.4.2 Arthritis
2.4.3 Sprains
2.4.4 Everyday Injuries
2.4.5 Other
2.5 Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application
2.5.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Breakdown Data by Company
3.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Company (2019-2024)
3.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Company (2019-2024)
3.2.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Company
3.4 Key Manufacturers Topical Non-Steroidal Anti-Inflammatory Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Topical Non-Steroidal Anti-Inflammatory Drugs Product Location Distribution
3.4.2 Players Topical Non-Steroidal Anti-Inflammatory Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TOPICAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Topical Non-Steroidal Anti-Inflammatory Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth
4.4 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth
4.5 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth
4.6 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth
5 AMERICAS
5.1 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country
5.1.1 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024)
5.1.2 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024)
5.2 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
5.3 Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region
6.1.1 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2024)
6.1.2 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2024)
6.2 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
6.3 APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Topical Non-Steroidal Anti-Inflammatory Drugs by Country
7.1.1 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024)
7.1.2 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024)
7.2 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
7.3 Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs by Country
8.1.1 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Topical Non-Steroidal Anti-Inflammatory Drugs
10.3 Manufacturing Process Analysis of Topical Non-Steroidal Anti-Inflammatory Drugs
10.4 Industry Chain Structure of Topical Non-Steroidal Anti-Inflammatory Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Topical Non-Steroidal Anti-Inflammatory Drugs Distributors
11.3 Topical Non-Steroidal Anti-Inflammatory Drugs Customer
12 WORLD FORECAST REVIEW FOR TOPICAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY GEOGRAPHIC REGION
12.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Region
12.1.1 Global Topical Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2025-2030)
12.1.2 Global Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Topical Non-Steroidal Anti-Inflammatory Drugs Forecast by Type (2025-2030)
12.7 Global Topical Non-Steroidal Anti-Inflammatory Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.1.3 Roche Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Viatris
13.2.1 Viatris Company Information
13.2.2 Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.2.3 Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Viatris Main Business Overview
13.2.5 Viatris Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.4.3 Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.5.3 Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.7.3 Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Zydus Cadila
13.8.1 Zydus Cadila Company Information
13.8.2 Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.8.3 Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zydus Cadila Main Business Overview
13.8.5 Zydus Cadila Latest Developments
13.9 Boehringer Ingelheim International
13.9.1 Boehringer Ingelheim International Company Information
13.9.2 Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.9.3 Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Boehringer Ingelheim International Main Business Overview
13.9.5 Boehringer Ingelheim International Latest Developments
13.10 Apotex
13.10.1 Apotex Company Information
13.10.2 Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.10.3 Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Apotex Main Business Overview
13.10.5 Apotex Latest Developments
13.11 AstraZeneca
13.11.1 AstraZeneca Company Information
13.11.2 AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.11.3 AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AstraZeneca Main Business Overview
13.11.5 AstraZeneca Latest Developments
13.12 Horizon Therapeutics
13.12.1 Horizon Therapeutics Company Information
13.12.2 Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.12.3 Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Horizon Therapeutics Main Business Overview
13.12.5 Horizon Therapeutics Latest Developments
13.13 Johnson & Johnson
13.13.1 Johnson & Johnson Company Information
13.13.2 Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.13.3 Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Johnson & Johnson Main Business Overview
13.13.5 Johnson & Johnson Latest Developments
13.14 Bayer
13.14.1 Bayer Company Information
13.14.2 Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.14.3 Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Bayer Main Business Overview
13.14.5 Bayer Latest Developments
13.15 Perrigo Company
13.15.1 Perrigo Company Company Information
13.15.2 Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.15.3 Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Perrigo Company Main Business Overview
13.15.5 Perrigo Company Latest Developments
13.16 Tolmar Pharmaceuticals
13.16.1 Tolmar Pharmaceuticals Company Information
13.16.2 Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.16.3 Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Tolmar Pharmaceuticals Main Business Overview
13.16.5 Tolmar Pharmaceuticals Latest Developments
13.17 Sun Pharmaceutical Industries
13.17.1 Sun Pharmaceutical Industries Company Information
13.17.2 Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.17.3 Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Sun Pharmaceutical Industries Main Business Overview
13.17.5 Sun Pharmaceutical Industries Latest Developments
13.18 Assertio Therapeutics
13.18.1 Assertio Therapeutics Company Information
13.18.2 Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.18.3 Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Assertio Therapeutics Main Business Overview
13.18.5 Assertio Therapeutics Latest Developments
13.19 Daiichi Sankyo
13.19.1 Daiichi Sankyo Company Information
13.19.2 Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
13.19.3 Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Daiichi Sankyo Main Business Overview
13.19.5 Daiichi Sankyo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Gel
Table 4. Major Players of Cream
Table 5. Major Players of Liquid Spray
Table 6. Major Players of Paste
Table 7. Major Players of Other
Table 8. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 9. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Table 10. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2019-2024) & ($ million)
Table 11. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2024)
Table 12. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale by Application (2019-2024) & (K Units)
Table 14. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Market Share by Application (2019-2024)
Table 15. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2019-2024) & ($ million)
Table 16. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2019-2024)
Table 17. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Company (2019-2024) & (K Units)
Table 19. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Company (2019-2024)
Table 20. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Company (2019-2024)
Table 22. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Topical Non-Steroidal Anti-Inflammatory Drugs Producing Area Distribution and Sales Area
Table 24. Players Topical Non-Steroidal Anti-Inflammatory Drugs Products Offered
Table 25. Topical Non-Steroidal Anti-Inflammatory Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Geographic Region (2019-2024)
Table 30. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2019-2024)
Table 34. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 37. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2024)
Table 38. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 40. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024) & (K Units)
Table 41. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2024) & (K Units)
Table 42. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2019-2024)
Table 43. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 45. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024) & (K Units)
Table 46. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 49. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 53. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Topical Non-Steroidal Anti-Inflammatory Drugs
Table 55. Key Market Challenges & Risks of Topical Non-Steroidal Anti-Inflammatory Drugs
Table 56. Key Industry Trends of Topical Non-Steroidal Anti-Inflammatory Drugs
Table 57. Topical Non-Steroidal Anti-Inflammatory Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Topical Non-Steroidal Anti-Inflammatory Drugs Distributors List
Table 60. Topical Non-Steroidal Anti-Inflammatory Drugs Customer List
Table 61. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 64. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 66. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 72. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 74. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. Roche Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Roche Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 77. Roche Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Roche Main Business
Table 79. Roche Latest Developments
Table 80. Viatris Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 82. Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Viatris Main Business
Table 84. Viatris Latest Developments
Table 85. Teva Pharmaceutical Industries Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 87. Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Teva Pharmaceutical Industries Main Business
Table 89. Teva Pharmaceutical Industries Latest Developments
Table 90. Sanofi Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 92. Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Pfizer Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 97. Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. GlaxoSmithKline Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 102. GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. Novartis Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 107. Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Novartis Main Business
Table 109. Novartis Latest Developments
Table 110. Zydus Cadila Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 112. Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zydus Cadila Main Business
Table 114. Zydus Cadila Latest Developments
Table 115. Boehringer Ingelheim International Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 117. Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Boehringer Ingelheim International Main Business
Table 119. Boehringer Ingelheim International Latest Developments
Table 120. Apotex Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 122. Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Apotex Main Business
Table 124. Apotex Latest Developments
Table 125. AstraZeneca Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 127. AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. AstraZeneca Main Business
Table 129. AstraZeneca Latest Developments
Table 130. Horizon Therapeutics Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 132. Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Horizon Therapeutics Main Business
Table 134. Horizon Therapeutics Latest Developments
Table 135. Johnson & Johnson Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 137. Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Johnson & Johnson Main Business
Table 139. Johnson & Johnson Latest Developments
Table 140. Bayer Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 142. Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Bayer Main Business
Table 144. Bayer Latest Developments
Table 145. Perrigo Company Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 147. Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Perrigo Company Main Business
Table 149. Perrigo Company Latest Developments
Table 150. Tolmar Pharmaceuticals Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 152. Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Tolmar Pharmaceuticals Main Business
Table 154. Tolmar Pharmaceuticals Latest Developments
Table 155. Sun Pharmaceutical Industries Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 157. Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Sun Pharmaceutical Industries Main Business
Table 159. Sun Pharmaceutical Industries Latest Developments
Table 160. Assertio Therapeutics Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 162. Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Assertio Therapeutics Main Business
Table 164. Assertio Therapeutics Latest Developments
Table 165. Daiichi Sankyo Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 167. Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Daiichi Sankyo Main Business
Table 169. Daiichi Sankyo Latest Developments
Table 1. Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Topical Non-Steroidal Anti-Inflammatory Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Gel
Table 4. Major Players of Cream
Table 5. Major Players of Liquid Spray
Table 6. Major Players of Paste
Table 7. Major Players of Other
Table 8. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 9. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Table 10. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2019-2024) & ($ million)
Table 11. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2024)
Table 12. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale by Application (2019-2024) & (K Units)
Table 14. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Market Share by Application (2019-2024)
Table 15. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2019-2024) & ($ million)
Table 16. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2019-2024)
Table 17. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Company (2019-2024) & (K Units)
Table 19. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Company (2019-2024)
Table 20. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Company (2019-2024)
Table 22. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Topical Non-Steroidal Anti-Inflammatory Drugs Producing Area Distribution and Sales Area
Table 24. Players Topical Non-Steroidal Anti-Inflammatory Drugs Products Offered
Table 25. Topical Non-Steroidal Anti-Inflammatory Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Geographic Region (2019-2024)
Table 30. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2019-2024)
Table 34. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 37. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2024)
Table 38. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 40. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024) & (K Units)
Table 41. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2024) & (K Units)
Table 42. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2019-2024)
Table 43. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 45. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024) & (K Units)
Table 46. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 49. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024) & (K Units)
Table 53. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Topical Non-Steroidal Anti-Inflammatory Drugs
Table 55. Key Market Challenges & Risks of Topical Non-Steroidal Anti-Inflammatory Drugs
Table 56. Key Industry Trends of Topical Non-Steroidal Anti-Inflammatory Drugs
Table 57. Topical Non-Steroidal Anti-Inflammatory Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Topical Non-Steroidal Anti-Inflammatory Drugs Distributors List
Table 60. Topical Non-Steroidal Anti-Inflammatory Drugs Customer List
Table 61. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 64. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 66. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 72. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 74. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. Roche Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Roche Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 77. Roche Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Roche Main Business
Table 79. Roche Latest Developments
Table 80. Viatris Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 82. Viatris Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Viatris Main Business
Table 84. Viatris Latest Developments
Table 85. Teva Pharmaceutical Industries Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 87. Teva Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Teva Pharmaceutical Industries Main Business
Table 89. Teva Pharmaceutical Industries Latest Developments
Table 90. Sanofi Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 92. Sanofi Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Pfizer Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 97. Pfizer Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. GlaxoSmithKline Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 102. GlaxoSmithKline Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. Novartis Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 107. Novartis Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Novartis Main Business
Table 109. Novartis Latest Developments
Table 110. Zydus Cadila Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 112. Zydus Cadila Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zydus Cadila Main Business
Table 114. Zydus Cadila Latest Developments
Table 115. Boehringer Ingelheim International Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 117. Boehringer Ingelheim International Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Boehringer Ingelheim International Main Business
Table 119. Boehringer Ingelheim International Latest Developments
Table 120. Apotex Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 122. Apotex Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Apotex Main Business
Table 124. Apotex Latest Developments
Table 125. AstraZeneca Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 127. AstraZeneca Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. AstraZeneca Main Business
Table 129. AstraZeneca Latest Developments
Table 130. Horizon Therapeutics Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 132. Horizon Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Horizon Therapeutics Main Business
Table 134. Horizon Therapeutics Latest Developments
Table 135. Johnson & Johnson Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 137. Johnson & Johnson Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Johnson & Johnson Main Business
Table 139. Johnson & Johnson Latest Developments
Table 140. Bayer Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 142. Bayer Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Bayer Main Business
Table 144. Bayer Latest Developments
Table 145. Perrigo Company Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 147. Perrigo Company Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Perrigo Company Main Business
Table 149. Perrigo Company Latest Developments
Table 150. Tolmar Pharmaceuticals Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 152. Tolmar Pharmaceuticals Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Tolmar Pharmaceuticals Main Business
Table 154. Tolmar Pharmaceuticals Latest Developments
Table 155. Sun Pharmaceutical Industries Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 157. Sun Pharmaceutical Industries Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Sun Pharmaceutical Industries Main Business
Table 159. Sun Pharmaceutical Industries Latest Developments
Table 160. Assertio Therapeutics Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 162. Assertio Therapeutics Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Assertio Therapeutics Main Business
Table 164. Assertio Therapeutics Latest Developments
Table 165. Daiichi Sankyo Basic Information, Topical Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Product Portfolios and Specifications
Table 167. Daiichi Sankyo Topical Non-Steroidal Anti-Inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Daiichi Sankyo Main Business
Table 169. Daiichi Sankyo Latest Developments
LIST OF FIGURES
Figure 1. Picture of Topical Non-Steroidal Anti-Inflammatory Drugs
Figure 2. Topical Non-Steroidal Anti-Inflammatory Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2023)
Figure 10. Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Gel
Figure 12. Product Picture of Cream
Figure 13. Product Picture of Liquid Spray
Figure 14. Product Picture of Paste
Figure 15. Product Picture of Other
Figure 16. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type in 2023
Figure 17. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2024)
Figure 18. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Skin Inflammation
Figure 19. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Skin Inflammation (2019-2024) & (K Units)
Figure 20. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Arthritis
Figure 21. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Arthritis (2019-2024) & (K Units)
Figure 22. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Sprains
Figure 23. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Sprains (2019-2024) & (K Units)
Figure 24. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Everyday Injuries
Figure 25. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Everyday Injuries (2019-2024) & (K Units)
Figure 26. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Other
Figure 27. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Other (2019-2024) & (K Units)
Figure 28. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Market Share by Application (2023)
Figure 29. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application in 2023
Figure 30. Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Company in 2023 (K Units)
Figure 31. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Company in 2023
Figure 32. Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Company in 2023 ($ millions)
Figure 33. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Company in 2023
Figure 34. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2024 (K Units)
Figure 37. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2024 ($ millions)
Figure 38. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2024 (K Units)
Figure 39. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2024 ($ millions)
Figure 40. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2024 (K Units)
Figure 41. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2024 ($ millions)
Figure 42. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2024 ($ millions)
Figure 44. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country in 2023
Figure 45. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2024)
Figure 46. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Figure 47. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Figure 48. United States Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 49. Canada Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 50. Mexico Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 51. Brazil Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region in 2023
Figure 53. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2019-2024)
Figure 54. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Figure 55. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Figure 56. China Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. Japan Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. South Korea Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 59. Southeast Asia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 60. India Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 61. Australia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 62. China Taiwan Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country in 2023
Figure 64. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2024)
Figure 65. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Figure 66. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Figure 67. Germany Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 68. France Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. UK Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 70. Italy Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71. Russia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2024)
Figure 73. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Figure 74. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Figure 75. Egypt Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 76. South Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 77. Israel Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 78. Turkey Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 79. GCC Countries Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Topical Non-Steroidal Anti-Inflammatory Drugs in 2023
Figure 81. Manufacturing Process Analysis of Topical Non-Steroidal Anti-Inflammatory Drugs
Figure 82. Industry Chain Structure of Topical Non-Steroidal Anti-Inflammatory Drugs
Figure 83. Channels of Distribution
Figure 84. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Forecast by Region (2025-2030)
Figure 85. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 86. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 87. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 88. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 89. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Topical Non-Steroidal Anti-Inflammatory Drugs
Figure 2. Topical Non-Steroidal Anti-Inflammatory Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2023)
Figure 10. Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Gel
Figure 12. Product Picture of Cream
Figure 13. Product Picture of Liquid Spray
Figure 14. Product Picture of Paste
Figure 15. Product Picture of Other
Figure 16. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type in 2023
Figure 17. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2024)
Figure 18. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Skin Inflammation
Figure 19. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Skin Inflammation (2019-2024) & (K Units)
Figure 20. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Arthritis
Figure 21. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Arthritis (2019-2024) & (K Units)
Figure 22. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Sprains
Figure 23. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Sprains (2019-2024) & (K Units)
Figure 24. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Everyday Injuries
Figure 25. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Everyday Injuries (2019-2024) & (K Units)
Figure 26. Topical Non-Steroidal Anti-Inflammatory Drugs Consumed in Other
Figure 27. Global Topical Non-Steroidal Anti-Inflammatory Drugs Market: Other (2019-2024) & (K Units)
Figure 28. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sale Market Share by Application (2023)
Figure 29. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application in 2023
Figure 30. Topical Non-Steroidal Anti-Inflammatory Drugs Sales by Company in 2023 (K Units)
Figure 31. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Company in 2023
Figure 32. Topical Non-Steroidal Anti-Inflammatory Drugs Revenue by Company in 2023 ($ millions)
Figure 33. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Company in 2023
Figure 34. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2024 (K Units)
Figure 37. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2024 ($ millions)
Figure 38. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2024 (K Units)
Figure 39. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2024 ($ millions)
Figure 40. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2024 (K Units)
Figure 41. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2024 ($ millions)
Figure 42. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2024 ($ millions)
Figure 44. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country in 2023
Figure 45. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2024)
Figure 46. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Figure 47. Americas Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Figure 48. United States Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 49. Canada Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 50. Mexico Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 51. Brazil Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region in 2023
Figure 53. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2019-2024)
Figure 54. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Figure 55. APAC Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Figure 56. China Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. Japan Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. South Korea Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 59. Southeast Asia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 60. India Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 61. Australia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 62. China Taiwan Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country in 2023
Figure 64. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2024)
Figure 65. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Figure 66. Europe Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Figure 67. Germany Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 68. France Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. UK Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 70. Italy Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71. Russia Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2024)
Figure 73. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
Figure 74. Middle East & Africa Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
Figure 75. Egypt Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 76. South Africa Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 77. Israel Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 78. Turkey Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 79. GCC Countries Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Growth 2019-2024 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Topical Non-Steroidal Anti-Inflammatory Drugs in 2023
Figure 81. Manufacturing Process Analysis of Topical Non-Steroidal Anti-Inflammatory Drugs
Figure 82. Industry Chain Structure of Topical Non-Steroidal Anti-Inflammatory Drugs
Figure 83. Channels of Distribution
Figure 84. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Forecast by Region (2025-2030)
Figure 85. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 86. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 87. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 88. Global Topical Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 89. Global Topical Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Forecast by Application (2025-2030)
